Jane Street’s Precision BioSciences DTIL Stock Holding History

Jane Street’s Portfolio DTIL Stock Details DTIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$104K	Buy	+18,993	New	+$87.6K	﹤0.01%	10628
2025 Q1	–	Sell	-38,364	Closed	-$146K	–	9658
2024 Q4	$146K	Buy	+38,364	New	+$280K	﹤0.01%	8597
2023 Q2	–	Sell	-688	Closed	-$15.6K	–	8846
2023 Q1	$15.6K	Sell	688 -2,120	-75%	-$69.9K	﹤0.01%	8690
2022 Q4	$100K	Buy	2,808 +2,198	+360%	+$86.9K	﹤0.01%	8090
2022 Q3	$24K	Buy	+610	New	+$29K	﹤0.01%	9150
2022 Q2	–	Sell	-467	Closed	-$43K	–	9868
2022 Q1	$43K	Buy	+467	New	+$63.4K	﹤0.01%	9740
2021 Q4	–	Sell	-856	Closed	-$296K	–	10199
2021 Q3	$296K	Sell	856 -913	-52%	-$309K	﹤0.01%	8213
2021 Q2	$665K	Buy	+1,769	New	+$531K	﹤0.01%	6695
2021 Q1	–	Sell	-992	Closed	-$249K	–	9176
2020 Q4	$249K	Buy	+992	New	+$243K	﹤0.01%	6668

Other funds holding DTIL

OCA

Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

EAM

Empery Asset Management New York $83M AUM

Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

LCM

Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

AAA

Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Jane Street's DTIL Position: Q1 2026 in Review

Jane Street opened a new position in Precision BioSciences (DTIL) in Q1 2026: 18,993 shares worth $104K. The stake represents ﹤0.01% of the portfolio and ranks #10628 among its holdings. This is a return to the name: Jane Street previously reported a position in DTIL as recently as Q4 2024.

Jane Street first reported a position in DTIL in Q4 2020 and has held it in 9 quarters since. The position peaked at $665K in Q2 2021. 78 funds tracked by Wall St. Rank hold DTIL as of Q1 2026.

Jane Street held 18,993 shares of Precision BioSciences worth $104K as of Q1 2026.
Precision BioSciences was a new Jane Street position in Q1 2026.
Precision BioSciences made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #10628 holding.
Jane Street first reported a position in Precision BioSciences in Q4 2020 and has held it in 9 quarters since.
Jane Street's Precision BioSciences position peaked at $665K in Q2 2021.
78 funds tracked by Wall St. Rank held Precision BioSciences as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.